International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma

Autor: Lee, Anne W., Ng, Wai Tong, Pan, Jian Ji, Poh, Sharon S., Ahn, Yong Chan, AlHussain, Hussain, Corry, June, Grau, Cai, Grégoire, Vincent, Harrington, Kevin J., Hu, Chao Su, Kwong, Dora L., Langendijk, Johannes A., Le, Quynh Thu, Lee, Nancy Y., Lin, Jin Ching, Lu, Tai Xiang, Mendenhall, William M., O'Sullivan, Brian, Ozyar, Enis, Peters, Lester J., Rosenthal, David I., Soong, Yoke Lim, Tao, Yungan, Yom, Sue S., Wee, Joseph T.

Publikováno v: In Radiotherapy and Oncology January 2018 126(1):25-36

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Erratum to: Lee AW, Ng WT, Pan JJ, et al. International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys 2019;105:567-580

Autor: Lee, Anne W, Ng, Wai Tong, Pan, Jian Ji, Chiang, Chi-Leung, Poh, Sharon S, Choi, Horace C, Ahn, Yong Chan, AlHussain, Hussain, Corry, June, Grau, Cai, Grégoire, Vincent, Harrington, Kevin J, Hu, Chao Su, Kwong, Dora L, Langendijk, Johannes A, Le, Quynh Thu, Lee, Nancy Y, Lin, Jin Ching, Lu, Tai Xiang, Mendenhall, William M, O'Sullivan, Brian, Ozyar, Enis, Peters, Lester J, Rosenthal, David I, Sanguineti, Giuseppe, Soong, Yoke Lim, Tao, Yungan, Yom, Sue S, Wee, Joseph T

Publikováno v: International journal of radiation oncology, biology, physics, Vol. 105, no.5, p. 1166-1167 (2019)

In Table 2 of the above-referenced article, the Desirable dose of Thyroid should have read “V50

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1493::964337f0b8b1dc97d13e84f353b2c941
https://hdl.handle.net/2078.1/239506

The impact of the COVID-19 pandemic on nasopharyngeal carcinoma patients - a national cancer centre experience.

Autor: Poh SS; Division of Radiation Oncology, Duke-NUS Graduate Medical School, National Cancer Centre Singapore, Singapore, Singapore.; Duke-NUS Graduate Medical School, Oncology Academic Clinical Programme, Singapore, Singapore., Tan BF; Division of Radiation Oncology, Duke-NUS Graduate Medical School, National Cancer Centre Singapore, Singapore, Singapore., Yong FY; Division of Radiation Oncology, Duke-NUS Graduate Medical School, National Cancer Centre Singapore, Singapore, Singapore., Fong KW; Division of Radiation Oncology, Duke-NUS Graduate Medical School, National Cancer Centre Singapore, Singapore, Singapore.; Duke-NUS Graduate Medical School, Oncology Academic Clinical Programme, Singapore, Singapore., Wee JTS; Division of Radiation Oncology, Duke-NUS Graduate Medical School, National Cancer Centre Singapore, Singapore, Singapore.; Duke-NUS Graduate Medical School, Oncology Academic Clinical Programme, Singapore, Singapore., Tan TWK; Division of Radiation Oncology, Duke-NUS Graduate Medical School, National Cancer Centre Singapore, Singapore, Singapore.; Duke-NUS Graduate Medical School, Oncology Academic Clinical Programme, Singapore, Singapore., Chua MLK; Division of Radiation Oncology, Duke-NUS Graduate Medical School, National Cancer Centre Singapore, Singapore, Singapore.; Duke-NUS Graduate Medical School, Oncology Academic Clinical Programme, Singapore, Singapore., Sommat K; Division of Radiation Oncology, Duke-NUS Graduate Medical School, National Cancer Centre Singapore, Singapore, Singapore.; Duke-NUS Graduate Medical School, Oncology Academic Clinical Programme, Singapore, Singapore., Wang FQ; Division of Radiation Oncology, Duke-NUS Graduate Medical School, National Cancer Centre Singapore, Singapore, Singapore.; Duke-NUS Graduate Medical School, Oncology Academic Clinical Programme, Singapore, Singapore., Soong YL; Division of Radiation Oncology, Duke-NUS Graduate Medical School, National Cancer Centre Singapore, Singapore, Singapore.; Duke-NUS Graduate Medical School, Oncology Academic Clinical Programme, Singapore, Singapore.

Publikováno v: Holistic integrative oncology [Holist Integr Oncol] 2023; Vol. 2 (1), pp. 17. Date of Electronic Publication: 2023 Jun 07.

Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients.

Autor: Blanchard P; Department of Radiation Oncology, Gustave Roussy Cancer Campus, Université Paris-Sud, Université Paris-Saclay, Villejuif, France Gustave-Roussy, Villejuif, France.; Oncostat U1018 INSERM, labeled Ligue Contre le Cancer, Villejuif, France., Lee AWM; University of Hong Kong - Shenzhen Hospital, University of Hong-Kong, China., Carmel A; Oncostat U1018 INSERM, labeled Ligue Contre le Cancer, Villejuif, France.; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France., Wai Tong N; University of Hong Kong - Shenzhen Hospital, University of Hong-Kong, China., Ma J; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, China., Chan ATC; State Key Laboratory of Translational Oncology, Hong Kong Cancer Institute, The Chinese University of Hong Kong, Hong Kong, China., Hong RL; National Taiwan University Hospital, Taipei, Taiwan., Chen MY; Sun Yat-sen University Cancer Center, Guangzhou, China., Chen L; Sun Yat-sen University Cancer Center, Guangzhou, China., Li WF; Sun Yat-sen University Cancer Center, Guangzhou, China., Huang PY; Sun Yat-sen University Cancer Center, Guangzhou, China., Kwong DLW; Department of Clinical Oncology, University of Hong Kong, Hong Kong, China., Poh SSX; National Cancer Center, Singapore., Ngan R; University of Hong Kong - Shenzhen Hospital, University of Hong-Kong, China., Mai HQ; Sun Yat-sen University Cancer Center, Guangzhou, China., Ollivier C; Oncostat U1018 INSERM, labeled Ligue Contre le Cancer, Villejuif, France.; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France., Fountzilas G; Aristotle University of Thessaloniki School of Medicine, Thessaloniki, and Hellenic Cooperative Oncology Group, Athens, Greece and German Oncology Center, Limassol, Cyprus., Zhang L; Sun Yat-sen University Cancer Center, Guangzhou, China., Bourhis J; Department of Radiotherapy, Centre hospitalier universitaire vaudois, Lausanne, Switzerland., Aupérin A; Oncostat U1018 INSERM, labeled Ligue Contre le Cancer, Villejuif, France.; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France., Lacas B; Oncostat U1018 INSERM, labeled Ligue Contre le Cancer, Villejuif, France.; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France., Pignon JP; Oncostat U1018 INSERM, labeled Ligue Contre le Cancer, Villejuif, France.; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, Villejuif, France.

Publikováno v: Clinical and translational radiation oncology [Clin Transl Radiat Oncol] 2021 Nov 26; Vol. 32, pp. 59-68. Date of Electronic Publication: 2021 Nov 26 (Print Publication: 2022).